Molecular and cellular biological analyzes of morphogenesis modulated by HGF
HGF 调节形态发生的分子和细胞生物学分析
基本信息
- 批准号:08408027
- 负责人:
- 金额:$ 23.42万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (A)
- 财政年份:1996
- 资助国家:日本
- 起止时间:1996 至 1998
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
1. Rats fed ethanol-containing diets for 37 days showed remarkable increase in hepatic lipids and lipid droplet accumulation in the hepatocytes, indicating the onset of alcholic fatty liver. Administration of hepatocyte growth factor (HGF) for the last seven days of ethanol treatment markedly decreased hepatic lipids to the level lower than that seen before HGF treatment.2. In a rat model of lethal liver cirrhosis produced by dimethylnitrosamine administrations, repeated transfections of the human HGF gene into skeletal muscles induced ahigh plasmalevel of human as well as endogeneous rat HGF, and tyrosine phosphorylation of the c-Met/HGR receptor. Transduction with the HGF gene also inhibited fibrogenesis and hepatocyte appoptosis, and produced the complete resolution of fibrosis in the cirrhotic liver, thereby improving the survival rate of rats with this severe illness.3. The mice, a spontaneous mouse model for chronic renal disease (ICGN strain), progressively developed glomerular … More sclerotic injury, tubular atrophy and renal disfunction until they were 17 wk of age. Administration of HGF for 4-wk-periods(from weeks 14-17) prevented the progression of renal dysfunction and fibrosis in a spontaneous mouse model for chronic renal disease (ICGN strain).4. HGF was produced in cardiomyocytes and cardiac endothelial cells in culture, and in viable border zone of reperfused myocardiac infarction. Administration of HGF and HGF gene markedly decreased infarct area and apoptotic cradiac cell death in rat postreperfusion myocardial injury, compared with saline treatment.5. HGF prevented cerebral corteical neuronal cell induced by glutamate.6. Continuous intra-ventricular administration of HGF by mini-pump attenuated delayed neuronal cell death of cerebral cortex in acute brain ischemic model.7. We have previously demonstrated a four-kringle-containing fragment of HGF, HGF/NK4 inhibits invasion of tumors in vivo, as well as in vitro, and HGF/NK4 also competitively inhibited the binding of HGF to Met/HGF receptor on GB-d1 human gallbladder carcinoma cells, increased apoptosis of implanted GE-d1 apoptotic cell death and inhibited this tumor growth in vivo. In addition to the antagonistic activity against HGF, HGF/NK4 inhibited angiogenesis induced by FGF, VEGF and HGF in vitro and in vivo, and decreased growth size and angiogenesis of tumors, such as Luwis lung cancer cells, suggesting bipotential role of HGF for tumor grwoth and invasion. Less
1. 连续喂食含乙醇饮食37天的大鼠,肝脂质和肝细胞内脂滴积累显着增加,表明在乙醇治疗的最后7天给予肝细胞生长因子(HGF)显着发病。肝脂质水平低于HGF治疗前的水平。2.在通过二甲基亚硝胺给药产生的致死性肝硬化大鼠模型中,重复转染将人类 HGF 基因导入骨骼肌可诱导人类以及内源性大鼠 HGF 血浆水平升高,并且用 HGF 基因转导 c-Met/HGR 受体的酪氨酸磷酸化也可抑制纤维形成和肝细胞凋亡,并完全消除纤维化。 3. 慢性肾病自发小鼠模型(ICGN品系),在自发性小鼠模型中,肾小球逐渐出现硬化损伤、肾小管萎缩和肾功能障碍,直到 17 周龄时,连续 4 周(从第 14 周到第 17 周)施用 HGF 可以阻止肾功能障碍和纤维化的进展。用于慢性肾病(ICGN菌株)。4.在培养的心肌细胞和心脏内皮细胞中以及在再灌注心肌的活边界区中产生HGF。与盐水治疗相比,给予HGF和HGF基因可显着减少大鼠再灌注心肌损伤中的梗死面积和凋亡性心肌细胞死亡。5.微型泵减轻了急性脑缺血模型中大脑皮层的延迟性神经细胞死亡。7。 HGF的四环片段,HGF/NK4在体内和体外抑制肿瘤的侵袭,并且HGF/NK4还竞争性抑制HGF与GB-d1人胆囊癌细胞上的Met/HGF受体的结合,增加植入的 GE-d1 凋亡细胞死亡并抑制体内肿瘤生长。除了对 HGF 的拮抗活性外,HGF/NK4 还抑制由 HGF 诱导的血管生成。 FGF、VEGF 和 HGF 在体外和体内的作用,以及肿瘤(例如 Lewis 肺癌细胞)的生长大小和血管生成的减少,表明 HGF 对肿瘤生长和侵袭的双潜能作用较小。
项目成果
期刊论文数量(230)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Y.Nakamura: "A vaschlar modulator,hepatocyte growth factor(HGF),is associated with systolic blood pressure." Hypertension. 28. 409-413 (1996)
Y.Nakamura:“肝细胞生长因子 (HGF) 是一种血管调节剂,与收缩压有关。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
K.Liu, et al.: "Protamine enhances the proliferative activity of hepatocyte growth factor in rats." Am.J.Physiol.274. G21-G28 (1998)
K.Liu 等人:“鱼精蛋白增强大鼠肝细胞生长因子的增殖活性。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
K.Matsumoto & T.Nakamura: "The Proceedings of the Second International Symposium of Tissue Engineering for Therapeutic Use." Churchill Livingstone in press, (1998)
松本康
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
K.Date et al.: "Inhibition of tumor growth and invasion by a four-kringle antagonist(HGF/NK4)for hepatocyte growth fator." Oncogene. 17. 3045-3054 (1998)
K.Date 等人:“肝细胞生长因子的四环拮抗剂 (HGF/NK4) 抑制肿瘤生长和侵袭。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
T.Adachi: "Mitogen-sctivated protein kinese sctivation in hepatocyte growth factor-stimulated rat hepatocytes:Involvement of protein tyrosine kinase and protein kinese C." Hepatology. 23. 1244-1253 (1996)
T.Adachi:“肝细胞生长因子刺激的大鼠肝细胞中丝裂原激活的蛋白激酶激活:蛋白酪氨酸激酶和蛋白激酶 C 的参与。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NAKAMURA Toshikazu其他文献
NAKAMURA Toshikazu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NAKAMURA Toshikazu', 18)}}的其他基金
DISTANCE MEASUREMENTS OF FIBROUS PRION PROTEINS BY PULSE ESR SPECTROSCOPY
通过脉冲 ESR 光谱法测量纤维状朊病毒蛋白的距离
- 批准号:
24654112 - 财政年份:2012
- 资助金额:
$ 23.42万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Analysis of molecular mechanisms that reciprocally regulate growth and differentiation of mature hepatocytes
成熟肝细胞生长和分化相互调节的分子机制分析
- 批准号:
21390079 - 财政年份:2009
- 资助金额:
$ 23.42万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Investigation of Spin Dynamics and Development of Devices for Low-Dimensional Electronic Phases
自旋动力学研究和低维电子相器件的开发
- 批准号:
20340095 - 财政年份:2008
- 资助金额:
$ 23.42万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular Mechanisms of Tissue Regeneration through the Conversion of HGF Receptor Signaling in Response of Injury
通过损伤反应中 HGF 受体信号转导实现组织再生的分子机制
- 批准号:
18390087 - 财政年份:2006
- 资助金额:
$ 23.42万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular Basis of Anti-fibrosis via Destruction of an Organ Self-repair System
通过破坏器官自我修复系统抗纤维化的分子基础
- 批准号:
14207005 - 财政年份:2002
- 资助金额:
$ 23.42万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Investigation of the electronic states in the successive SDW transitions of one-dimensional organic conductors
一维有机导体连续 SDW 跃迁中电子态的研究
- 批准号:
13640375 - 财政年份:2001
- 资助金额:
$ 23.42万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Studies on Tissue Morphogenesis, Organogenesis and Repair by HGF
HGF 的组织形态发生、器官发生和修复研究
- 批准号:
11308025 - 财政年份:1999
- 资助金额:
$ 23.42万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Inhibitory effects of HGF antagonist on invasion/metastasis of tumor cells.
HGF拮抗剂对肿瘤细胞侵袭/转移的抑制作用。
- 批准号:
07557199 - 财政年份:1995
- 资助金额:
$ 23.42万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Molecular mechanisms of organ regeneration and homeoslasis by injurin/HGF system.
Injurin/HGF 系统器官再生和稳态的分子机制。
- 批准号:
05404080 - 财政年份:1993
- 资助金额:
$ 23.42万 - 项目类别:
Grant-in-Aid for General Scientific Research (A)
Development of Large Scale Expression, Preparation, and Highly Sensitive Immunoassay Methods for Hepatocyte Growth Factor
肝细胞生长因子大规模表达、制备和高灵敏免疫分析方法的开发
- 批准号:
03558020 - 财政年份:1991
- 资助金额:
$ 23.42万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
相似国自然基金
肝细胞源MIF招募CD74+胰腺癌细胞介导非酒精性脂肪肝(NAFLD)驱动的胰腺癌肝转移的机制研究
- 批准号:82303933
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
蛋鸡脂肪肝早期发生及叶酸对其缓解的表观遗传机制
- 批准号:32372910
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
BMSC外泌体调控中性粒细胞胞外诱捕网形成减轻脂肪肝肝移植缺血再灌注损伤的机制研究
- 批准号:82300750
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
GW441756基于重塑Thrap3转录调控网络改善非酒精性脂肪肝的新机制
- 批准号:82304586
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于谱效关系与代谢组学探究藏红曲抗非酒精性脂肪肝的物质基础及作用机制
- 批准号:82360825
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Tumor-promoting and tumor-suppressive roles of Hepatic Stellate Cell Subpopulations in NASH-HCC
肝星状细胞亚群在 NASH-HCC 中的促肿瘤和抑肿瘤作用
- 批准号:
10278434 - 财政年份:2021
- 资助金额:
$ 23.42万 - 项目类别:
Tumor-promoting and tumor-suppressive roles of Hepatic Stellate Cell Subpopulations in NASH-HCC
肝星状细胞亚群在 NASH-HCC 中的促肿瘤和抑肿瘤作用
- 批准号:
10454375 - 财政年份:2021
- 资助金额:
$ 23.42万 - 项目类别:
Tumor-promoting and tumor-suppressive roles of Hepatic Stellate Cell Subpopulations in NASH-HCC
肝星状细胞亚群在 NASH-HCC 中的促肿瘤和抑肿瘤作用
- 批准号:
10654714 - 财政年份:2021
- 资助金额:
$ 23.42万 - 项目类别:
Adbanced therapy for liver fibrosis and cirrhosis by adipose derived mesenchymal stem cell
脂肪间充质干细胞治疗肝纤维化和肝硬化
- 批准号:
23659847 - 财政年份:2011
- 资助金额:
$ 23.42万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research